Raymond James Financial’s Organogenesis Holdings ORGO Stock Holding History
Bought
Maintained
Sold
Other funds holding ORGO
Raymond James Financial's ORGO Position: Q3 2026 in Review
Raymond James Financial reduced its Organogenesis Holdings (ORGO) stake by 92% in Q3 2026, selling an estimated $338K and leaving 14,700 shares worth $20.1K. The position accounts for ﹤0.01% of the portfolio, ranked #5367.
Raymond James Financial first reported a position in ORGO in Q1 2025 and has held it in 7 quarters since. The position peaked at $2.18M in Q4 2025. 123 funds tracked by Wall St. Rank hold ORGO as of Q3 2026.
- Raymond James Financial held 14,700 shares of Organogenesis Holdings worth $20.1K as of Q3 2026.
- Raymond James Financial sold 172,277 Organogenesis Holdings shares in Q3 2026, an estimated $338K.
- Organogenesis Holdings made up ﹤0.01% of Raymond James Financial's portfolio in Q3 2026, its #5367 holding.
- Raymond James Financial first reported a position in Organogenesis Holdings in Q1 2025 and has held it in 7 quarters since.
- Raymond James Financial's Organogenesis Holdings position peaked at $2.18M in Q4 2025.
- 123 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q3 2026.
Based on Raymond James Financial's 13F filing for Q3 2026, filed 12 Nov 2026.